LABORATORY NEWS
-
Precision BioLogic Leads The Way In Hemophilia Testing
Precision BioLogic Inc., a leading developer of hemostasis diagnostic products, is pleased to announce the expanded utility of its CRYOcheck Chromogenic Factor VIII assay in anticipation of emerging hemophilia treatments such as Mim8, a next generation bispecific antibody for the treatment of hemophilia A.
- QIAGEN Secures European CE-IVDR Certification For Full QIAstat-Dx Portfolio
- Prinses Máxima Center For Pediatric Oncology Implements Callisto™ From Volta Labs To Streamline Clinical Genomics Workflows
- Exact Sciences Launches Cancerguard™, First-Of-Its-Kind Multi-Cancer Early Detection Blood Test
- OptraSCAN To Introduce HER2 Scan + Analyze Pilot At CAP 2025
ARCHIVED NEWSLETTER
- 09.09.25 -- Nearly 40% Of Biomanufacturers Eyeing Continuous Processing
- 08.26.25 -- Environmental Monitoring Performance Qualification In New Drug Manufacturing Facilities
- 08.12.25 -- Innovative Liquid Biopsy Test Uses RNA To Detect Early-Stage Cancer
- 07.22.25 -- Essential Steps For A Successful Analytical Tech Transfer
- 07.08.25 -- Formulation Development Of A JAK1 Inhibitor Extended-Release Tablet